Patti, F <br/><br/>
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Aug 2011 
 - 991-1001 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458511401943  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Cognition Disorders--drug therapy<br/>Depression--drug therapy<br/>Fatigue--drug therapy<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--complications<br/>Quality of Life<br/>Young Adult